World Tuberculosis Day 2014 The TB situation in 2012: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office for Europe ECDC TB Team European Centre for Disease Prevention and Control Stockholm, 24 March 2014
World Tuberculosis Day 2014
Feb 23, 2016
World Tuberculosis Day 2014. The TB situation in 2012 : Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office for Europe . ECDC TB Team European Centre for Disease Prevention and Control Stockholm, 24 March 2014. - PowerPoint PPT Presentation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
World Tuberculosis Day 2014The TB situation in 2012: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office for Europe
ECDC TB TeamEuropean Centre for Disease Prevention and ControlStockholm, 24 March 2014
MonitoringFour epidemiological indicatorsEight core indicators
2
Epidemiological indicators
3
Indicator 1: Trends in case notification rate 2008−2012 Target: Mean declining trend over the previous five yearsStatus 2012: 21 countries met the target
4
Figure 1: Trend in TB notification rate, EU/EEA, 2008−2012
2008 2009 2010 2011 20120
5
10
15
20
16.6 15.8 15.0 14.3 13.5
Year of reporting
Notifi
catio
n ra
te p
er 1
00 0
00 p
opul
atio
n
Indicator 2: Trends in multidrug-resistant TB case notification rateTarget: Mean declining trend in MDR TB over the previous five yearsStatus 2012: 7 countries met the target
5
Figure 2: Multidrug-resistant TB notification rate per 100 000 by year, EU/EEA, 2008−2012
2008 2009 2010 2011 20120.0
0.1
0.2
0.3
0.40.34 0.33
0.31 0.310.28
Year of reporting
Notifi
catio
n ra
te p
er 1
00 0
00 p
opu-
latio
n
Indicator 3: Trends in child-to-adult notification ratioTarget: Mean declining 10-year trend in child-to-adult notification ratioStatus 2012: Three countries reported a declining trend
6
Figure 3: Child-to-adult TB notification ratio, EU/EEA, 2003−2012
2003 2004 2005 2006 2007 2008 2009 2010 2011 20120.0
0.1
0.2
0.3
0.4
Year of reporting
Child
-to-a
dult
ratio
Indicator 4: Trends in mean age of TB casesTarget: Increasing 10-year trendStatus 2012: Twelve countries met the target
7
Figure 4: Trend in mean age of TB cases, EU/EEA, 2003−2012
2003 2004 2005 2006 2007 2008 2009 2010 2011 201240
42
44
46
48
50
Year of reporting
Mea
n ag
e (y
ears
)
Core indicators
8
Indicator 1 and 2: Availability of national TB control plan and implementation guidelines
9
• 13 countries have a national TB control plan • 11 countries have a plan and guidelines for
implementation
Information not available or country not reporting
National TB control plan not available
National TB control plan available with implementation guidelinesNational TB control plan available
Figure 5: Availability of a national TB control plan and implementation guidelines, EU/EEA, 2012
Indicator 3: Percentage of national TB reference laboratories achieving adequate performance in the external quality assessment (EQA) scheme
10* Results for 2012 report obtained from European Reference Laboratory Network for Tuberculosis (ERLN-TB) for smear microscopy, culture, and drug susceptibility testing for first- and second-line TB drugs. No country-specific data are available.
Target: 100% of national TB reference laboratories achieving ≥ 80% performance (smear, culture, first- and second-line drug susceptibility testing).
Status 2012*: Nineteen laboratories participated in the EQA for all four diagnostic methods and 18 (95%) laboratories achieved a performance of ≥ 80% for all four methods.
Indicator 4: Availability of a strategy for introducing and implementing new tools for TB control
11
Target: All Member States (100%) have a strategy within the national TB programme supporting the introduction and implementation of new tools for TB control.Status 2012: Seven countries have a strategy in place.
Figure 6: Availability of a strategy for introducing and implementing new tools for TB control, by country, EU/EEA, 2012
Information not available or country not reporting
Strategy for new tools for TB control not available
Strategy for new tools for TB control available
Indicator 5: Percentage of new pulmonary TB cases confirmed by cultureTarget: 80% of new pulmonary TB cases are culture confirmed.Status 2012: 69.8% of new pulmonary TB cases were culture confirmed, 11 countries met the target.
12
Figure 7: Percentage of new pulmonary TB cases confirmed by culture by country, EU/EEA, 2012
EU/EE
A
Sloven
ia
Swed
enEst
oniaCy
prus
Belgium
Norway
Irelan
dLat
via
Finlan
d
Netherl
ands
Portug
al
Denmark
German
y
Lithua
nia
Czech
Repu..
.Sp
ain
Roman
iaAu
stria
Polan
d
United
Kin...
Bulgari
a
Slovak
ia
Icelan
dFra
nce
Hunga
ryGree
ce Italy
Malta
0
10
20
30
40
50
60
70
80
90
100%
Indicator 5: Percentage of new pulmonary TB cases tested by DST for first-line drugs
13
Figure 8: Percentage of new pulmonary TB cases tested for susceptibility to first line drugs, by country, EU/EEA, 2012
50 to 84.9%
100%
< 50%
85 to 99.9%
Not included or not reporting
Target: 100% of TB cases tested for susceptibility to first-line drugs (isoniazid and rifampicin) among new pulmonary TB cases.Status 2012: For 77.6% of culture-confirmed TB cases, DST results for first line drugs were reported; seven countries met the 100% target.
Target: All Member States (100%) report treatment outcome monitoring to ECDC.Status 2012: 26 EU/EEA Member States reported treatment outcome for new culture-confirmed pulmonaryTB cases notified in 2011.
Indicator 6: Percentage of Member States reporting treatment success rate
14
Figure 9: Treatment outcome reporting for new pulmonary TB cases notified in 2011, by country, EU/EEA, 2012
Treatment outcome not reported
Treatment outcome reported
Indicator 7: Treatment success rateTarget: Treatment success rate of at least 85% for new pulmonary culture-confirmed TB cases.Status 2012: Treatment success rate for EU/EEA was 76.5% (range: 0–91.3%), target met by three countries.
15
Figure 10: Treatment success rate in culture-confirmed new pulmonary TB cases notified in 2011, by country, EU/EEA, 2012
* Iceland and Malta reported zero new TB cases in 2011. Three EU/EEA Member States did not report treatment outcome data
EU/EE
AAus
tria
Belgium
Bulgaria
Cyprus
Czech Rep
ublic
Denmark
Eston
ia
Finlan
d
German
y
HungaryIre
landLat
via
Lithuan
iaMalt
a
Netherl
ands
NorwayPo
land
Portu
gal
Roman
ia
Slovak
ia
Sloven
iaSpain
Sweden
United Kingdom
0
20
40
60
80
100
Trea
tmen
t suc
cess
(%)
EU/EE
AAust
ria
Belgium
Bulgari
a
Czech R
epu..
.
Denmark
Eston
ia
German
y
Hunga
ry
Irelan
dLa
tvia
Lithu
ania
Netherl
ands
Norway
Polan
d
Portu
gal
Roman
ia
Swed
en
United
Kin..
.0
20
40
60
80
100
Trea
tmen
t suc
cess
(%)
Target: Treatment success of 70% of new pulmonary culture-positive MDR TB casesStatus 2012: Success rate in EU/EEA was 47.6% (range 0–100.0%), target met by 4 countriesFigure 11: 24-month treatment success rate in new pulmonary culture positive multidrug-resistant TB cases notified in 2010, by country, EU/EEA, 2012
Indicator 7: Treatment success rate new pulmonary culture positive MDR TB cases*
16* Cyprus, Iceland, Malta, Slovakia and Slovenia reported zero MDR TB cases in 2010, seven Member States did not report stratified treatment outcome data
Indicator 8: Percentage of TB patients for whom HIV status is known
17
Figure 12: Percentage of TB cases with HIV status reported, by country, EU/EEA, 2012
50 to 74.9%
100%
< 50%
75 to 99.9%
Not included or not reporting
Target: HIV status is known for 100% of notified TB cases.Status 2012: 16 countries (60.6%) reported HIV test results, one country met the 100% target.
Related Documents
